MFS Meridian Funds - Continental European Equity Fund W1 USDRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.4 | 19.5 | -4.8 | 10.9 | 4.1 | |
+/-Cat | 0.0 | 4.1 | 3.9 | -2.6 | 1.5 | |
+/-B’mrk | 1.5 | 2.3 | 2.6 | -4.0 | -0.4 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 22/11/2024 | USD 20.55 | |
Day Change | 1.19% | |
Morningstar Category™ | Europe ex-UK Equity | |
ISIN | LU1529512300 | |
Fund Size (Mil) 22/11/2024 | EUR 68.91 | |
Share Class Size (Mil) 31/10/2024 | EUR 0.10 | |
Max Initial Charge | - | |
Ongoing Charge 17/02/2023 | 0.86% |
Investment Objective: MFS Meridian Funds - Continental European Equity Fund W1 USD |
The Fund’s objective is capital appreciation, measured in euros. The Fund invests primarily (at least 70%) in continental European equity securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Matthew Barrett 03/01/2009 | ||
Inception Date 14/12/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for MFS Meridian Funds - Continental European Equity Fund W1 USD | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
SAP SE | Technology | 6.26 |
Schneider Electric SE | Industrials | 5.59 |
Roche Holding AG | Healthcare | 5.27 |
Linde PLC | Basic Materials | 4.84 |
Novartis AG Registered Shares | Healthcare | 4.74 |
Increase Decrease New since last portfolio | ||
MFS Meridian Funds - Continental European Equity Fund W1 USD |